Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 31.32

+1.3%

Nov 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: T. Mann who wrote (117)	4/17/1997 6:29:00 PM
From: Douglas	of 455

On September 7, 1996 Procept presented preclinical data on its PRO 2000 topical gel formulation at the First Annual Meeting of Dr. Robert Gallo's Institute of Human Virology in Baltimore. The gel was shown to be well tolerated in a rabbit vaginal irritation study, and did not induce skin sensitization in guinea pigs. PRO 2000 topical gel was also shown to be compatible with latex condoms. The British Medical Research Councial must of thought the data was good, they gave a research grant of $1,000,000.00 for Procept's Phase I that is ongoing in London.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next